Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy
Rubel Chakravarty(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), K. V. Vimalnath Nair(Bhabha Atomic Research Centre), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Sudipta Chakraborty, Amit Kunwar(Bhabha Atomic Research Centre), Chandan Kumar(University of Michigan), Apurav Guleria(Bhabha Atomic Research Centre)
Cited by 47
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Comparative study of copper(II)–curcumin complexes as superoxide dismutase mimics and free radical scavengers
|European Journal of Medicinal Chemistry|2006|163
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117